Sudafed PE Congestion

Product NDC
50580-546
Requested package NDC
50580-546-50
11-digit product format
505800546
Labeler code
50580
Product ID
50580-546_da52fc7a-771b-ad90-e053-2a95a90a3ca3
Type
HUMAN OTC DRUG
Nonproprietary name
Phenylephrine Hydrochloride
Dosage form
TABLET
Route
ORAL
Labeler
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2015-07-13
Marketing end
0000-00-00
Substance
PHENYLEPHRINE HYDROCHLORIDE
Active strength
10 mg/1
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage50580-54650580-546-50DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50580-546-50EA - Each50580-5465c8d7237-63a5-4368-9e3e-0de4073ff12612016-10-06
50580-546-51EA - Each50580-546ca9fc025-d4bb-451d-be9e-f328cf7b7e2812017-12-14

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Phenylephrine HydrochlorideACTIVE INGREDIENT04JA59TNSJSUDAFED PE CONGESTION (PHENYLEPHRINE HYDROCHLORIDE) TABLET [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]2
PhenylephrineACTIVE MOIETY1WS297W6MVSUDAFED PE CONGESTION (PHENYLEPHRINE HYDROCHLORIDE) TABLET [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]2
aluminum oxideINACTIVE INGREDIENTLMI26O6933SUDAFED PE CONGESTION (PHENYLEPHRINE HYDROCHLORIDE) TABLET [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]2
carnauba waxINACTIVE INGREDIENTR12CBM0EIZSUDAFED PE CONGESTION (PHENYLEPHRINE HYDROCHLORIDE) TABLET [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]2
cellulose, microcrystallineINACTIVE INGREDIENTOP1R32D61USUDAFED PE CONGESTION (PHENYLEPHRINE HYDROCHLORIDE) TABLET [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]2
D&C yellow no. 10INACTIVE INGREDIENT35SW5USQ3GSUDAFED PE CONGESTION (PHENYLEPHRINE HYDROCHLORIDE) TABLET [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]2
FD&C red no. 40INACTIVE INGREDIENTWZB9127XOASUDAFED PE CONGESTION (PHENYLEPHRINE HYDROCHLORIDE) TABLET [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]2
FD&C yellow no. 6INACTIVE INGREDIENTH77VEI93A8SUDAFED PE CONGESTION (PHENYLEPHRINE HYDROCHLORIDE) TABLET [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]2
magnesium stearateINACTIVE INGREDIENT70097M6I30SUDAFED PE CONGESTION (PHENYLEPHRINE HYDROCHLORIDE) TABLET [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]2
polyethylene glycolsINACTIVE INGREDIENT3WJQ0SDW1ASUDAFED PE CONGESTION (PHENYLEPHRINE HYDROCHLORIDE) TABLET [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]2
polyvinyl alcoholINACTIVE INGREDIENT532B59J990SUDAFED PE CONGESTION (PHENYLEPHRINE HYDROCHLORIDE) TABLET [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]2
powdered celluloseINACTIVE INGREDIENTSMD1X3XO9MSUDAFED PE CONGESTION (PHENYLEPHRINE HYDROCHLORIDE) TABLET [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]2
sodium starch glycolate Type A potatoINACTIVE INGREDIENT5856J3G2A2SUDAFED PE CONGESTION (PHENYLEPHRINE HYDROCHLORIDE) TABLET [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]2
talcINACTIVE INGREDIENT7SEV7J4R1USUDAFED PE CONGESTION (PHENYLEPHRINE HYDROCHLORIDE) TABLET [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]2
titanium dioxideINACTIVE INGREDIENT15FIX9V2JPSUDAFED PE CONGESTION (PHENYLEPHRINE HYDROCHLORIDE) TABLET [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50580-546-50505800546501 BLISTER PACK in 1 CARTON (50580-546-50) > 18 TABLET in 1 BLISTER PACK1 blister pack2015-07-130000-00-00NoNoCurrent